Search
forResearch 10 of 169
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Neuregulin3 alters cell fate in the epidermis and mammary gland
- Genetically modified laboratory mice with sebaceous glands abnormalities
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- 646 SOX4 is essential for melanoma tumorigenesis
- Deciphering the Mesodermal Potency of Porcine Skin-Derived Progenitors (SKP) by Microarray Analysis
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →